XML 24 R2.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Balance Sheets (USD $)
In Thousands, unless otherwise specified
Sep. 30, 2014
Dec. 31, 2013
Current assets:    
Cash and cash equivalents $ 48,492 $ 48,131
Restricted cash 250  
Receivables 91 92
Prepaid and other current assets 972 1,448
Total current assets 49,805 49,671
Property and equipment, net 582 400
Other assets 2,966 353
Total assets 53,353 50,424
Current liabilities:    
Accounts payable 1,432 619
Accrued clinical and cost of other studies 1,669 1,831
Accrued compensation 833 198
Deferred revenue 1,172 4,379
Facility lease exit obligation 187 168
Other accrued liabilities 247 82
Total current liabilities 5,540 7,277
Deferred rent 108 132
Facility lease exit obligation, non-current 153 297
Deferred revenue, long term 7,839  
Note payable, net of discount and accrued interest   9,035
Total liabilities 13,640 16,741
Commitments and contingencies      
Shareholders' equity:    
Preferred stock, 5,000,000 shares authorized, none outstanding      
Common stock, no par value; authorized shares: 25,045,765 at September 30, 2014 and December 31, 2013; issued and outstanding shares: 14,709,409 at September 30, 2014; 14,681,274 at December 31, 2013 427,154 426,607
Accumulated deficit (387,441) (392,924)
Total shareholders' equity 39,713 33,683
Total liabilities and shareholders' equity $ 53,353 $ 50,424